How to Help Your Patients Find Zenzedi in Stock: A Provider's Guide

How to Help Your Patients Find Zenzedi in Stock

Your patients who take Zenzedi (dextroamphetamine sulfate) for ADHD or narcolepsy are likely telling you the same thing: they can't find it. As a prescriber, you're in a unique position to help — both by understanding the supply landscape and by taking proactive steps to improve your patients' access to this medication.

This guide provides practical strategies your practice can implement today.

The Current State of Zenzedi Availability in 2026

Zenzedi remains one of the most difficult ADHD medications to find in 2026, with a findability score of 35 out of 100. While the DEA's 25% amphetamine production quota increase in October 2025 has begun to improve overall stimulant supply, brand Zenzedi — as a low-volume, single-manufacturer product — has seen less improvement than higher-volume generics.

Key facts for your practice:

• Azurity Pharmaceuticals is the sole manufacturer of Zenzedi
• Most chain pharmacies do not routinely stock it
• Wholesaler allocation for Zenzedi is limited or zero at many locations
• The 2024 voluntary recall disrupted distribution and some pharmacies have not resumed stocking

Why Your Patients Still Can't Find Zenzedi

Wholesaler Allocation Limits

The three major pharmaceutical wholesalers (McKesson, Cardinal Health, AmerisourceBergen) allocate controlled substances based on historical purchasing patterns. Since Zenzedi is a low-volume product at most pharmacy locations, many pharmacies receive zero allocation — meaning they cannot order it even when they want to.

Demand Concentration

The relatively small number of patients on Zenzedi (compared to Adderall or Vyvanse) means that when a pharmacy does stock it, a single patient's monthly fill can deplete their entire supply. This creates a cycle where pharmacies are frequently "out" even when they technically carry the product.

Pharmacy Economics

From a pharmacy's perspective, stocking Zenzedi carries financial risk: it ties up inventory dollars in a slow-moving, expensive brand product with unpredictable demand. Many pharmacy buyers choose to allocate their controlled substance purchasing budgets to higher-volume products instead.

Post-Recall Caution

Following Azurity's 2024 voluntary recall, some pharmacies and their corporate buyers became more conservative about ordering Zenzedi, preferring to stock only generic dextroamphetamine or redirecting patients to alternative stimulants.

What You Can Do to Help Your Patients

1. Use the Medfinder Provider Portal

The Medfinder provider portal allows you to search for Zenzedi availability at pharmacies on behalf of your patients. The support team contacts pharmacies directly to verify real-time stock, then reports back with options. This can be delegated to a medical assistant or nurse and integrated into your prescribing workflow.

2. Advise Patients to Plan Ahead

Counsel your Zenzedi patients to contact their pharmacy at least one week before their refill is due. This gives the pharmacy time to order the medication from their wholesaler or find an alternative source. Waiting until the last day creates unnecessary emergencies.

3. Recommend Independent Pharmacies

Independent pharmacies often have access to secondary wholesalers and more flexibility in sourcing niche medications. They may also participate in the Arbor E-Z Rx pharmacy network (4,000+ locations), which has a direct relationship with Azurity for Zenzedi distribution.

Keeping a short list of reliable independent pharmacies in your area that stock Zenzedi (or can order it) saves time for both your practice and your patients.

4. Prescribe with Flexibility in Mind

When clinically appropriate, consider these strategies:

• Prefer common dose strengths: The 10 mg and 20 mg tablets are generally more available than the 2.5 mg, 7.5 mg, or 15 mg strengths
• Allow generic substitution: Unless the patient has documented issues with generic dextroamphetamine, writing for "dextroamphetamine sulfate" rather than "Zenzedi" broadens pharmacy options
• Consider dose consolidation: If a patient takes 7.5 mg TID, prescribing 15 mg BID (if clinically equivalent) reduces the number of tablets needed and may improve fillability

5. Ensure Patients Know About Savings Programs

Cost can compound the access problem. Make sure patients know about:

• Azurity/Arbor Zenzedi Savings Card: Cash-paying patients pay no more than $75/Rx; insured patients may get their first Rx free, then $30/refill
• Generic pricing: $30–$80 for 60 tablets with GoodRx or SingleCare coupons
• Azurity Patient Assistance Program: For uninsured or underinsured patients meeting income criteria

40,111+ patients found their medications in stock

40K+

Find Zenzedi In Stock Today →

Alternative Options to Discuss with Patients

When Zenzedi is unavailable, these alternatives are worth discussing:

• Generic dextroamphetamine sulfate IR: Same active ingredient, significantly cheaper, more widely available. First-line substitute for most patients.
• Adderall (mixed amphetamine salts): Contains dextroamphetamine plus levoamphetamine. Available in IR and XR. The most commonly stocked stimulant.
• Vyvanse / generic lisdexamfetamine: Prodrug of dextroamphetamine. Long-acting (12–14 hours). Lower abuse potential profile. Good option for patients who prefer once-daily dosing.
• Xelstrym (dextroamphetamine patch): Transdermal delivery of dextroamphetamine. Newer option. May be appropriate for patients who need steady-state levels or have GI absorption concerns.

Streamlining Your Practice Workflow

Designate a Point Person

Assign a medical assistant or nurse to handle medication access issues. This person can check Medfinder, call pharmacies, assist with savings program enrollment, and manage prior authorization paperwork — freeing up prescriber time for clinical decisions.

Build Availability Checks into Your Prescribing Process

Before sending a new Zenzedi prescription, have staff verify that the receiving pharmacy has it in stock. A two-minute check via Medfinder or a quick call prevents the patient from arriving at the pharmacy only to find it's unavailable.

Keep a Reliable Pharmacy List

Maintain a running list of pharmacies in your area that reliably carry Zenzedi or can order it within 1–2 business days. Update it quarterly. Share it with patients who are starting on Zenzedi for the first time.

Skip the calls, skip the stress.

Find Zenzedi In Stock Today →

50K+

Medications
Found

99%

Success
Rate

6+

Hours saved
on average

Final Thoughts

The Zenzedi shortage is frustrating for patients and providers alike, but proactive steps from your practice can make a meaningful difference:

1. Use Medfinder's provider portal to locate Zenzedi for patients
2. Recommend independent pharmacies and the Arbor E-Z Rx network
3. Prescribe common dose strengths and allow generic substitution when possible
4. Connect patients with the Azurity savings card to reduce cost barriers
5. Designate a staff member to manage medication access issues

For more provider resources:

• Zenzedi Shortage: What Providers Need to Know in 2026
• How to Help Your Patients Save Money on Zenzedi